160 related articles for article (PubMed ID: 23081865)
1. A flow cytometric method for viability assessment of Staphylococcus aureus and Burkholderia cepacia in mixed culture.
Rüger M; Bensch G; Tüngler R; Reichl U
Cytometry A; 2012 Dec; 81(12):1055-66. PubMed ID: 23081865
[TBL] [Abstract][Full Text] [Related]
2. Species-specific viability analysis of Pseudomonas aeruginosa, Burkholderia cepacia and Staphylococcus aureus in mixed culture by flow cytometry.
Rüger M; Ackermann M; Reichl U
BMC Microbiol; 2014 Mar; 14():56. PubMed ID: 24606608
[TBL] [Abstract][Full Text] [Related]
3. A novel concept combining experimental and mathematical analysis for the identification of unknown interspecies effects in a mixed culture.
Schmidt JK; Riedele C; Regestein L; Rausenberger J; Reichl U
Biotechnol Bioeng; 2011 Aug; 108(8):1900-11. PubMed ID: 21391206
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a three bacteria mixed culture in a chemostat: evaluation and application of a quantitative terminal-restriction fragment length polymorphism (T-RFLP) analysis for absolute and species specific cell enumeration.
Schmidt JK; König B; Reichl U
Biotechnol Bioeng; 2007 Mar; 96(4):738-56. PubMed ID: 16937400
[TBL] [Abstract][Full Text] [Related]
5. Interspecies effects in a ceftazidime-treated mixed culture of Pseudomonas aeruginosa, Burkholderia cepacia and Staphylococcus aureus: analysis at the single-species level.
Riedele C; Reichl U
J Antimicrob Chemother; 2011 Jan; 66(1):138-45. PubMed ID: 21062793
[TBL] [Abstract][Full Text] [Related]
6. Misidentification of Burkholderia cepacia in US cystic fibrosis treatment centers: an analysis of 1,051 recent sputum isolates.
McMenamin JD; Zaccone TM; Coenye T; Vandamme P; LiPuma JJ
Chest; 2000 Jun; 117(6):1661-5. PubMed ID: 10858399
[TBL] [Abstract][Full Text] [Related]
7. Identification of Burkholderia cepacia isolates from patients with cystic fibrosis and use of a simple new selective medium.
Henry DA; Campbell ME; LiPuma JJ; Speert DP
J Clin Microbiol; 1997 Mar; 35(3):614-9. PubMed ID: 9041399
[TBL] [Abstract][Full Text] [Related]
8. Comparison of culture and PCR for detection of Burkholderia cepacia in sputum samples of patients with cystic fibrosis.
Whitby PW; Dick HL; Campbell PW; Tullis DE; Matlow A; Stull TL
J Clin Microbiol; 1998 Jun; 36(6):1642-5. PubMed ID: 9620393
[TBL] [Abstract][Full Text] [Related]
9. Accuracy of four commercial systems for identification of Burkholderia cepacia and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis.
Kiska DL; Kerr A; Jones MC; Caracciolo JA; Eskridge B; Jordan M; Miller S; Hughes D; King N; Gilligan PH
J Clin Microbiol; 1996 Apr; 34(4):886-91. PubMed ID: 8815102
[TBL] [Abstract][Full Text] [Related]
10. PCR-based detection and identification of Burkholderia cepacia complex pathogens in sputum from cystic fibrosis patients.
McDowell A; Mahenthiralingam E; Moore JE; Dunbar KE; Webb AK; Dodd ME; Martin SL; Millar BC; Scott CJ; Crowe M; Elborn JS
J Clin Microbiol; 2001 Dec; 39(12):4247-55. PubMed ID: 11724828
[TBL] [Abstract][Full Text] [Related]
11. Comparison of isolation media for recovery of Burkholderia cepacia complex from respiratory secretions of patients with cystic fibrosis.
Henry D; Campbell M; McGimpsey C; Clarke A; Louden L; Burns JL; Roe MH; Vandamme P; Speert D
J Clin Microbiol; 1999 Apr; 37(4):1004-7. PubMed ID: 10074517
[TBL] [Abstract][Full Text] [Related]
12. [Isolation and identification of Burkholderia cepacia complex from cystic fibrosis patients].
Yurdakul P; Ergünay K; Yalçin E; Doğru D; Sener B; Cobanoğlu N; Ozçelik U; Kiper N
Mikrobiyol Bul; 2006 Oct; 40(4):301-6. PubMed ID: 17205687
[TBL] [Abstract][Full Text] [Related]
13. Utility of commercial systems for identification of Burkholderia cepacia complex from cystic fibrosis sputum culture.
Shelly DB; Spilker T; Gracely EJ; Coenye T; Vandamme P; LiPuma JJ
J Clin Microbiol; 2000 Aug; 38(8):3112-5. PubMed ID: 10921992
[TBL] [Abstract][Full Text] [Related]
14. Molecular epidemiology of Pseudomonas aeruginosa, Burkholderia cepacia complex and methicillin-resistant Staphylococcus aureus in a cystic fibrosis center.
Campana S; Taccetti G; Ravenni N; Masi I; Audino S; Sisi B; Repetto T; Döring G; de Martino M
J Cyst Fibros; 2004 Aug; 3(3):159-63. PubMed ID: 15463902
[TBL] [Abstract][Full Text] [Related]
15. Proteomic tracking and analysis of a bacterial mixed culture.
Kluge S; Hoffmann M; Benndorf D; Rapp E; Reichl U
Proteomics; 2012 Jun; 12(12):1893-901. PubMed ID: 22623171
[TBL] [Abstract][Full Text] [Related]
16. Flow cytometric viability assessment of lactic acid bacteria starter cultures produced by fluidized bed drying.
Bensch G; Rüger M; Wassermann M; Weinholz S; Reichl U; Cordes C
Appl Microbiol Biotechnol; 2014 Jun; 98(11):4897-909. PubMed ID: 24584512
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of restriction fragment length polymorphism analysis of 16S rDNA as a tool for genomovar characterisation within the Burkholderia cepacia complex.
Vermis K; Vandekerckhove C; Nelis HJ; Vandamme PA
FEMS Microbiol Lett; 2002 Aug; 214(1):1-5. PubMed ID: 12204364
[TBL] [Abstract][Full Text] [Related]
18. Exposure to extremely low-frequency magnetic field affects biofilm formation by cystic fibrosis pathogens.
Di Bonaventura G; Pompilio A; Crocetta V; De Nicola S; Barbaro F; Giuliani L; D'Emilia E; Fiscarelli E; Bellomo RG; Saggini R
Future Microbiol; 2014; 9(12):1303-17. PubMed ID: 25517897
[TBL] [Abstract][Full Text] [Related]
19. Misidentification of a genomovar of Burkholderia cepacia by recA restriction fragment length polymorphism.
Moore JE; Millar BC; Xu J; Crowe M; Redmond AO; Elborn JS
J Clin Pathol; 2002 Apr; 55(4):309-11. PubMed ID: 11919219
[TBL] [Abstract][Full Text] [Related]
20. Burkholderia cepacia complex: distribution of genomovars among isolates from the maize rhizosphere in Italy.
Fiore A; Laevens S; Bevivino A; Dalmastri C; Tabacchioni S; Vandamme P; Chiarini L
Environ Microbiol; 2001 Feb; 3(2):137-43. PubMed ID: 11321544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
